Results 111 to 120 of about 10,833,780 (300)

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Rational Control of Antibody Orientation for Enhancing Sensitivity and Specificity in Lateral Flow Immunoassays With Clinical Validation

Advanced Healthcare Materials, EarlyView.
Systematic investigation of antibody orientation strategies in lateral flow immunoassays reveals that a para‐substituted (aminomethyl)phenylboronic acid mediated probe (P‐6) combined with a biotin‐streptavidin test‐line modification achieves a synergistic 14‐ to 19‐fold sensitivity gain over conventional conjugation. Furthermore, multiplexed detection,
Pin‐Hao Wang, Shunmuga Nathan Shunmuga Nainar, Bing‐Han Zhuang, Shun‐Mao Yang, Hong‐Cheu Lin, Yang‐Hsiang Chan   +5 more
wiley   +1 more source

Polyphenol‐Inspired Materials for Agricultural Applications

Advanced Materials, EarlyView.
This review outlines the use of polyphenol‐inspired materials for sustainable agriculture, highlighting their molecular design, interfacial assembly, structure–property relationships, and prospects toward precision agriculture, climate resilience, ecosystem protection, and circular bioeconomy strategies.
Haofu Liu, Omid Mazaheri, Zhixing Lin, Tianzheng Wang, Jingqu Chen, Yuang Gu, Xia Liang, Deli Chen, Frank Caruso   +8 more
wiley   +1 more source

Gel point and fractal microstructure of incipient blood clots are significant new markers of hemostasis for healthy and anticoagulated blood

, 2010
Here we report the first application of a fractal analysis of the viscoelastic properties of incipient blood clots. We sought to ascertain whether the incipient clot's fractal dimension, Df, could be used as a functional biomarker of hemostasis.
Karl Hawkins, Rhodri Williams, Matthew Lawrence, Lisa Wakeman, Matthew J. Lawrence, Phillip A. Evans, Roger Munro, Adrian Evans, P. Rhodri Williams, Naresh Thirumalai, Roger H. K. Morris   +10 more
core   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility

BMC Pediatrics
Background ABO incompatibility is the most common blood group incompatibility in newborn babies, haemolytic disease develops in very few cases and is much milder than Rh incompatibility.
Kamil Sahin, Tahir Aydın, Demet Deniz Bilgin, Derya Büyükkayhan, Murat Elevli   +4 more
doaj   +1 more source

Sporophytic Self-Incompatibility

, 2017
Most flowering plants are hermaphrodites with flowers that have both male and female reproductive organs. Despite being able to self-fertilize, numerous mechanisms have evolved to prevent this from happening.
JCO Koh (9976760), Susan Hoebee (9495965), EJ Newbigin (9976763)   +2 more
core   +1 more source

Increasing Lipid Nanoparticle mRNA Copy Number Improves Transfection Potency

Advanced Materials, EarlyView.
As lipid nanoparticle (LNP) systems are the leading platform for in vivo nucleic acid delivery, improving transfection potency of these systems is of considerable interest. In this work, we explored a post‐mixing formulation method involving a two‐step buffer exchange that increased the number of mRNA copies within each LNP while reducing the number of
Yao Zhang, Jerry Leung, Judy Cheng, Arash Momeni, Albert Kamanzi, Ariadne Tuckmantel Bido, Suiyang Liao, Emma Kang, Colton Strong, Christian J. Kastrup, Sabrina Leslie, Miffy Hok Yan Cheng, Pieter R. Cullis   +12 more
wiley   +1 more source

Antea Group Archeologie 2018/153

, 2016
In september 2018 heeft Antea Group in opdracht van CroonenBuro5 een archeologisch booronderzoek (verkennende fase) uitgevoerd voor een plangebied dat valt binnen het grotere bestemmingsplan Slotjes te Oosterhout. Het plangebied bestaat uit verschillende
Arkema, Drs. M. (Antea Group), Teekens, Drs. P. (Antea Group), Riddersma, F.S. (Antea Group), Researcher, Fens, Drs. R.L. (Antea Group), Researcher, Fens, MA R.L. (Antea Group), Researcher, Fens, R.L. (Antea Group), Researcher, Teekens, P.C. (Antea Group), Researcher, Fens, MA RL (Antea Group), Fens, Drs. R. (Antea Group), Fens, R.L. (Antea Group), ProjectMember, Looveren, V Van (Antea Group), Fens, MA R.L. (Antea Group), Editor, Fens, MA R.L. (Antea Group), Fens, drs. RL (Antea Group), Pels-Ouweneel, Drs. A. (Antea Group), Sophie, Drs. G. (Antea Group), Colijn, MA J.E. (Antea Group), Fens, drs. R.L. (Antea Group), Munster, Drs. B. van (Antea Group), La Fèber, drs. D.J. (Antea Group), Fens, R. (Antea Group), Researcher, Nater, MA C.I. (Antea Group), Dasselaar, MA M. van (Antea Group), Fèber, D. la (Antea Group), Nater, MSC C.I. (Antea Group), Looveren, Drs. V. van (Antea Group), Fens, MA R. (Antea Group), Arkema, MA M. (Antea Group), Fèber, Drs. D. la (Antea Group), Fens, drs RL (Antea Group), Tolsma, drs. J. (Antea Group), Riddersma, F. (Antea Group), Researcher, Veen, V van der (Antea Group), Vossen, Drs. I. (Antea Group), Teekens, Drs. P.C. (Antea Group), Colijn, J.E. (Antea Group), Sophie, drs. G.J.A. (Antea Group), Bostelen, Drs. T. van (Antea Group), Fens, R.L. (Antea Group), RelatedPerson, Arkema, M.H. (Antea Group), Akkerman, E. (Antea Group), Fèber, drs D.J. la (Antea Group), Looveren, MA V. van (Antea Group), Fèber, drs. D.J. la (Antea Group), Sophie, MA G. (Antea Group), Craane, Dr. M.L. (Antea Group)   +45 more
core   +1 more source

Charge‐Reversed Lipid Nanoparticles Enable Encapsulation of Pt2L4 Nanocages for In vivo Anti‐Cancer Treatment

Advanced Materials, EarlyView.
Charge‐reversed lipid nanoparticles (revLNPs) enable efficient encapsulation and delivery of cationic Pt2L4 nanocages. Encapsulation preserves potent anticancer activity while improving circulation, reducing vascular leakage, and promoting favorable biodistribution in vivo.
Renzo A. Knol, Bochuan Hu, Eduard O. Bobylev, Martina Farber, Petrus C. M. Laan, Thomas J. F. Kock, Bauke Fontein, Johanna Erbani, Oscar Escalona‐Rayo, Seline S. Roose, Tom Keijer, Gabriel Forn‐Cuní, B. Ewa Snaar‐Jagalska, Leila Akkari, Joost N. H. Reek, Alexander Kros, Dennis Aschmann   +16 more
wiley   +1 more source